CAPITOL COUNSEL LLC

Lobbying for CMC PHARMACEUTICALS · Developing new and better drug formulations.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Ohio · House · Senate · $40,000.00 income · posted Oct 18, 2025

Lobbying activity 3

Budget/Appropriations

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection funding.

Defense

Issues related to the FY26 National Defense Authorization Act and Defense Appropriations.

Government Issues

Support for Department of Defense Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.